<--- Back to Details
First PageDocument Content
Biomarkers / Biotechnology / Chemical pathology / Medical emergencies / Cardiovascular disease / Myocardial infarction / Non-communicable disease / Hypertension / Rheumatoid arthritis / Medicine / Health / Biology
Date: 2014-05-14 13:42:40
Biomarkers
Biotechnology
Chemical pathology
Medical emergencies
Cardiovascular disease
Myocardial infarction
Non-communicable disease
Hypertension
Rheumatoid arthritis
Medicine
Health
Biology

Add to Reading List

Source URL: www.abcodia.com

Download Document from Source Website

File Size: 1,54 MB

Share Document on Facebook

Similar Documents

ONCOLOGY REPORTS 39: , 2018 Improving diagnosis, prognosis and prediction by using biomarkers in CRC patients (Review) Taxiarchis Konstantinos Nikolouzakis1, Loukia Vassilopoulou2, Persefoni Fragkiadaki2, Theod

DocID: 1vf63 - View Document

NEWS: How to use quantitative LC-MS/MS proteomics to study skin conditions A recent study (1) showed how quantitative LC-MS/MS proteomics allowed to find biomarkers candidates by comparison of skin biopsies from psoriasi

DocID: 1vdFN - View Document

TECHNOLOGY OFFER Novel platelet biomarkers for detection of thrombosis risk We hereby present novel biomarkers for the detection of platelet reactivity. These new biomarkers allow the risk estimation for people having a

DocID: 1v9bO - View Document

Invitation to the NANO WORLD CANCER DAY 2018 Precision Medicine for People – Smart Biomarkers, Nanotechnologies and more Date:

DocID: 1v8gO - View Document

BioCog_Brochure_Project_def_Layout:52 Pagina 1 BioCog is a FP7 project funded by the European Commission with the final aim of establishing valid biomarkers panels for risk analysis and clinical outcome pr

DocID: 1v5iF - View Document